Rhumbline Advisers trimmed its stake in Amdocs Limited (NASDAQ:DOX – Free Report) by 13.2% in the third quarter, HoldingsChannel reports. The firm owned 221,163 shares of the technology company’s stock after selling 33,518 shares during the period. Rhumbline Advisers’ holdings in Amdocs were worth $18,146,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in the stock. Harbor Capital Advisors Inc. acquired a new stake in shares of Amdocs in the 3rd quarter valued at about $26,000. Root Financial Partners LLC acquired a new stake in Amdocs in the third quarter valued at approximately $26,000. Atlantic Union Bankshares Corp acquired a new stake in Amdocs in the third quarter valued at approximately $37,000. Rossby Financial LCC bought a new stake in shares of Amdocs during the second quarter valued at approximately $41,000. Finally, Caitong International Asset Management Co. Ltd raised its position in shares of Amdocs by 537.8% during the second quarter. Caitong International Asset Management Co. Ltd now owns 472 shares of the technology company’s stock worth $43,000 after purchasing an additional 398 shares during the period. Institutional investors and hedge funds own 92.02% of the company’s stock.
Wall Street Analyst Weigh In
DOX has been the subject of several research reports. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Bank of America decreased their target price on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Barclays lowered their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, February 4th. Finally, Stifel Nicolaus cut their price target on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Amdocs presently has a consensus rating of “Moderate Buy” and an average price target of $92.33.
Amdocs Stock Down 1.2%
Amdocs stock opened at $68.42 on Wednesday. Amdocs Limited has a fifty-two week low of $66.53 and a fifty-two week high of $95.41. The firm’s 50-day simple moving average is $79.30 and its 200 day simple moving average is $81.48. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.17 and a current ratio of 1.06. The stock has a market cap of $7.39 billion, a PE ratio of 13.23, a price-to-earnings-growth ratio of 1.23 and a beta of 0.40.
Amdocs (NASDAQ:DOX – Get Free Report) last released its earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.06. The company had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.15 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.Amdocs’s quarterly revenue was up 4.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Research analysts predict that Amdocs Limited will post 6.21 EPS for the current fiscal year.
Amdocs Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be issued a $0.569 dividend. This is an increase from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.3%. Amdocs’s payout ratio is presently 40.81%.
Amdocs Profile
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Featured Articles
- Five stocks we like better than Amdocs
- Energy Security Is Now National Security – Positioning Is Happening Now
- The gold chart Wall Street is terrified of…
- The “Bomb” in America’s Basement
- Unlocked: Elon Musk’s Next Big IPO
- How to collect $1,170 a month from silver
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
